THEOPHYLLINE ANHYDROUS 300 KIARA


300 mg: white, round, flat tablet, scored on one side 60
scheduling status
S2
registration number
X/10.2/54
What THEOPHYLLINE ANHYDROUS 300 KIARA is and what it is used for
Treatment of reversible bronchospasm associated with bronchial asthma, chronic bronchitis and emphysema.
dosage
Adults: One tablet twice daily. This dose can be gradually increased after three days of treatment, or decreased by half if disturbing side effects occur. Serum theophylline levels should be monitored if side effects appear or if higher doses than those recommended, are needed.
how to take
The tablets should be swallowed whole (not chewed or crushed), with a glass of water and should be taken on an empty stomach.
What THEOPHYLLINE ANHYDROUS 300 KIARA contains
Each THEOPHYLLINE ANHYDROUS 300 KIARA sustained release tablet contains: 300 mg theophylline anhydrous.
other ingredients
Contains sugar (lactose 124,50 mg). Ethyl cellulose, lactose monohydrate, magnesium stearate, povidone, stearic acid.
Therapeutic classification
R03DA04.
© 2026 SAHPRA. ALL RIGHTS RESERVED